Protocol

Post-Authorization Safety Study to Assess the Risk of Diabetic Ketoacidosis Among Type 2 Diabetes Mellitus Patients Treated with Ertugliflozin Compared to Patients Treated with Other Antihyperglycemic Agents

October 17, 2019
Authors:

Harvard Pilgrim Health Care Institute, Reagan-Udall Foundation for FDA, CVS Health, Carelon Research, Humana HealthCare Research, Health Partners Institute, Marshfield Clinic Health System, Vanderbilt University Medical Center, Meyers Primary Care Institute, Optum Epidemiology, Merck Sharp & Dohme LLC

Capability:
Multi-Site Methods & Coordination
Expertise:
Regulatory Research & Support
RWE Research & Consulting